Agile Therapeutics to Present at Biotech Showcase 2019
December 18 2018 - 7:00AM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare
company, announced today that its Chairman and Chief Executive
Officer, Al Altomari will present at the Biotech Showcase 2019 on
Tuesday January 8, 2019 at 10:00 AM Pacific Time. The conference
will be held at the Hilton San Francisco Union Square.
To access the live and archived webcasts of the presentation,
visit the Investor Relations section of the Agile Therapeutics
website at www.agiletherapeutics.com. The webcast will be archived
on the Agile Therapeutics website for 60 days following the
event.
About Agile Therapeutics,
Inc.Agile Therapeutics is a forward-thinking women's
healthcare company dedicated to fulfilling the unmet health needs
of today’s women. Our product candidates are designed to provide
women with contraceptive options that offer freedom from taking a
daily pill, without committing to a longer-acting method. Our lead
product candidate, Twirla®, (ethinyl estradiol and levonorgestrel
transdermal system), also known as AG200-15, is an investigational
low-dose, non-daily prescription contraceptive. Twirla is based on
our proprietary transdermal patch technology, called Skinfusion®,
which is designed to allow drug delivery through the skin. For more
information, please visit the company website at
www.agiletherapeutics.com. The Company may occasionally disseminate
material, nonpublic information on the Company’s website.
Contact: Investor Relations -- 609-683-1880
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From Apr 2024 to May 2024
Agile Therapeutics (NASDAQ:AGRX)
Historical Stock Chart
From May 2023 to May 2024